Ariel Berlinski
Concepts (161)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Albuterol | 24 | 2022 | 58 | 10.360 |
Why?
| Nebulizers and Vaporizers | 29 | 2022 | 57 | 10.270 |
Why?
| Bronchodilator Agents | 27 | 2022 | 74 | 10.140 |
Why?
| Drug Delivery Systems | 17 | 2023 | 151 | 7.600 |
Why?
| Aerosols | 31 | 2022 | 76 | 7.280 |
Why?
| Administration, Inhalation | 27 | 2022 | 119 | 4.500 |
Why?
| Tracheostomy | 7 | 2023 | 81 | 3.330 |
Why?
| Metered Dose Inhalers | 8 | 2021 | 19 | 3.250 |
Why?
| Asthma | 8 | 2023 | 293 | 2.760 |
Why?
| Equipment Design | 22 | 2022 | 319 | 2.760 |
Why?
| Masks | 7 | 2016 | 31 | 2.610 |
Why?
| Respiration, Artificial | 6 | 2020 | 285 | 2.340 |
Why?
| Respiratory Therapy | 6 | 2023 | 38 | 2.160 |
Why?
| Cystic Fibrosis | 7 | 2022 | 157 | 2.070 |
Why?
| Spirometry | 3 | 2023 | 30 | 1.630 |
Why?
| Particle Size | 9 | 2021 | 88 | 1.580 |
Why?
| Child | 27 | 2023 | 7312 | 1.430 |
Why?
| Forced Expiratory Volume | 2 | 2020 | 46 | 1.250 |
Why?
| Home Care Services | 2 | 2020 | 79 | 1.180 |
Why?
| Tidal Volume | 6 | 2016 | 55 | 1.140 |
Why?
| High-Frequency Ventilation | 2 | 2019 | 16 | 1.130 |
Why?
| Humans | 53 | 2023 | 54132 | 1.090 |
Why?
| Ventilators, Mechanical | 4 | 2017 | 42 | 1.060 |
Why?
| Allied Health Personnel | 1 | 2023 | 33 | 0.920 |
Why?
| Positive-Pressure Respiration | 2 | 2014 | 61 | 0.910 |
Why?
| Respiration | 7 | 2019 | 98 | 0.910 |
Why?
| Status Asthmaticus | 1 | 2022 | 8 | 0.880 |
Why?
| Lung | 6 | 2022 | 512 | 0.880 |
Why?
| Outpatients | 1 | 2023 | 122 | 0.860 |
Why?
| Catheterization | 1 | 2023 | 109 | 0.860 |
Why?
| Body Height | 2 | 2021 | 77 | 0.800 |
Why?
| Noninvasive Ventilation | 2 | 2019 | 22 | 0.780 |
Why?
| Hydrocarbons, Fluorinated | 2 | 2017 | 8 | 0.780 |
Why?
| Pressure | 2 | 2018 | 121 | 0.780 |
Why?
| Surgical Mesh | 1 | 2020 | 20 | 0.770 |
Why?
| Child, Preschool | 13 | 2021 | 4132 | 0.730 |
Why?
| Curriculum | 1 | 2023 | 429 | 0.730 |
Why?
| Models, Anatomic | 6 | 2017 | 46 | 0.660 |
Why?
| Quality Improvement | 2 | 2018 | 242 | 0.630 |
Why?
| Time Factors | 4 | 2017 | 3223 | 0.610 |
Why?
| Lung Diseases | 3 | 2015 | 86 | 0.600 |
Why?
| Patients' Rooms | 1 | 2016 | 5 | 0.600 |
Why?
| Equipment Failure Analysis | 2 | 2013 | 49 | 0.570 |
Why?
| Models, Theoretical | 5 | 2015 | 185 | 0.570 |
Why?
| Respiratory Mechanics | 2 | 2013 | 38 | 0.570 |
Why?
| Infant | 11 | 2023 | 3797 | 0.560 |
Why?
| Nose | 2 | 2013 | 42 | 0.560 |
Why?
| Larynx | 2 | 2013 | 38 | 0.560 |
Why?
| Time-to-Treatment | 1 | 2016 | 74 | 0.560 |
Why?
| Patient Transfer | 1 | 2016 | 103 | 0.540 |
Why?
| Insufflation | 1 | 2015 | 9 | 0.540 |
Why?
| Technology Assessment, Biomedical | 1 | 2015 | 13 | 0.540 |
Why?
| Family Relations | 1 | 2015 | 26 | 0.530 |
Why?
| Airway Management | 1 | 2015 | 23 | 0.530 |
Why?
| Neuromuscular Diseases | 1 | 2015 | 33 | 0.520 |
Why?
| Cough | 1 | 2015 | 54 | 0.520 |
Why?
| Respiratory Rate | 2 | 2015 | 8 | 0.510 |
Why?
| Delivery of Health Care | 1 | 2018 | 327 | 0.510 |
Why?
| Respiratory Dead Space | 2 | 2014 | 2 | 0.510 |
Why?
| Life Style | 1 | 2015 | 157 | 0.500 |
Why?
| Intubation, Intratracheal | 2 | 2015 | 130 | 0.470 |
Why?
| Rural Population | 1 | 2018 | 599 | 0.450 |
Why?
| Filtration | 1 | 2012 | 20 | 0.430 |
Why?
| Severe Acute Respiratory Syndrome | 1 | 2012 | 15 | 0.430 |
Why?
| Models, Biological | 5 | 2014 | 824 | 0.430 |
Why?
| Emergency Service, Hospital | 1 | 2016 | 536 | 0.430 |
Why?
| Telemedicine | 1 | 2018 | 448 | 0.410 |
Why?
| Male | 16 | 2022 | 27350 | 0.410 |
Why?
| Spectrophotometry | 3 | 2019 | 36 | 0.410 |
Why?
| Adult | 8 | 2021 | 14196 | 0.390 |
Why?
| Female | 15 | 2022 | 28437 | 0.370 |
Why?
| Inhalation Spacers | 3 | 2016 | 8 | 0.360 |
Why?
| Cross-Over Studies | 2 | 2018 | 259 | 0.290 |
Why?
| Adolescent | 7 | 2021 | 6890 | 0.290 |
Why?
| Adrenergic beta-Agonists | 1 | 2006 | 43 | 0.280 |
Why?
| Educational Status | 1 | 2023 | 254 | 0.210 |
Why?
| Suspensions | 1 | 2021 | 6 | 0.210 |
Why?
| Bronchiolitis | 1 | 2021 | 28 | 0.200 |
Why?
| Electronic Health Records | 1 | 2023 | 204 | 0.200 |
Why?
| Materials Testing | 2 | 2010 | 62 | 0.190 |
Why?
| Budesonide | 1 | 2020 | 2 | 0.190 |
Why?
| Pediatrics | 2 | 2015 | 324 | 0.190 |
Why?
| Tropanes | 1 | 2020 | 5 | 0.190 |
Why?
| Anti-Asthmatic Agents | 1 | 2020 | 32 | 0.180 |
Why?
| Percussion | 1 | 2019 | 1 | 0.180 |
Why?
| Primary Health Care | 1 | 2023 | 400 | 0.170 |
Why?
| Length of Stay | 1 | 2022 | 683 | 0.170 |
Why?
| Monitoring, Physiologic | 1 | 2019 | 137 | 0.160 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 134 | 0.160 |
Why?
| Oxygen | 1 | 2021 | 358 | 0.160 |
Why?
| Infant, Newborn | 3 | 2015 | 2901 | 0.160 |
Why?
| Tertiary Care Centers | 1 | 2018 | 83 | 0.160 |
Why?
| Procaterol | 1 | 2017 | 2 | 0.160 |
Why?
| Diabetes Mellitus | 1 | 2021 | 307 | 0.150 |
Why?
| Community Health Services | 1 | 2018 | 115 | 0.150 |
Why?
| Random Allocation | 1 | 2017 | 315 | 0.150 |
Why?
| Decision Making | 2 | 2020 | 290 | 0.150 |
Why?
| Face | 2 | 2015 | 66 | 0.150 |
Why?
| Research Design | 1 | 2019 | 374 | 0.150 |
Why?
| Quality Assurance, Health Care | 1 | 2018 | 164 | 0.150 |
Why?
| Pneumonia, Viral | 1 | 2020 | 186 | 0.150 |
Why?
| Single-Blind Method | 1 | 2016 | 124 | 0.150 |
Why?
| Health Communication | 1 | 2017 | 26 | 0.140 |
Why?
| Coronavirus Infections | 1 | 2020 | 194 | 0.140 |
Why?
| Compressed Air | 1 | 2016 | 2 | 0.140 |
Why?
| Drug Administration Schedule | 1 | 2017 | 406 | 0.140 |
Why?
| Models, Statistical | 1 | 2018 | 259 | 0.140 |
Why?
| United States | 3 | 2018 | 5172 | 0.140 |
Why?
| Product Surveillance, Postmarketing | 1 | 2015 | 17 | 0.130 |
Why?
| Insurance, Health, Reimbursement | 1 | 2015 | 24 | 0.130 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2016 | 376 | 0.130 |
Why?
| Computer Simulation | 2 | 2013 | 333 | 0.130 |
Why?
| Administration, Intranasal | 1 | 2015 | 29 | 0.130 |
Why?
| Radiography | 2 | 2013 | 519 | 0.130 |
Why?
| Transition to Adult Care | 1 | 2015 | 13 | 0.130 |
Why?
| Radionuclide Imaging | 1 | 2014 | 130 | 0.120 |
Why?
| Respiratory Function Tests | 1 | 2014 | 98 | 0.120 |
Why?
| Nasal Sprays | 1 | 2013 | 3 | 0.120 |
Why?
| Head Movements | 1 | 2013 | 6 | 0.120 |
Why?
| Respiratory System | 1 | 2013 | 28 | 0.120 |
Why?
| Comparative Effectiveness Research | 1 | 2013 | 39 | 0.120 |
Why?
| Drug Monitoring | 1 | 2013 | 85 | 0.110 |
Why?
| Head | 1 | 2013 | 77 | 0.110 |
Why?
| Pharmaceutical Preparations | 1 | 2013 | 86 | 0.110 |
Why?
| Disposable Equipment | 1 | 2010 | 5 | 0.100 |
Why?
| Technology, Pharmaceutical | 1 | 2010 | 4 | 0.100 |
Why?
| Solutions | 1 | 2010 | 29 | 0.100 |
Why?
| Young Adult | 1 | 2020 | 4320 | 0.090 |
Why?
| Prognosis | 1 | 2014 | 2116 | 0.080 |
Why?
| Retrospective Studies | 3 | 2021 | 6387 | 0.080 |
Why?
| Treatment Outcome | 1 | 2019 | 5596 | 0.080 |
Why?
| Bronchoscopy | 1 | 2008 | 79 | 0.080 |
Why?
| Pneumonia, Staphylococcal | 1 | 2007 | 7 | 0.080 |
Why?
| Aging | 1 | 2012 | 786 | 0.070 |
Why?
| Cromolyn Sodium | 1 | 2006 | 1 | 0.070 |
Why?
| Fluocinolone Acetonide | 1 | 2006 | 6 | 0.070 |
Why?
| Tobramycin | 1 | 2006 | 14 | 0.070 |
Why?
| Drug Combinations | 1 | 2006 | 129 | 0.070 |
Why?
| Respiratory Insufficiency | 1 | 2007 | 129 | 0.070 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2007 | 308 | 0.060 |
Why?
| Saline Solution, Hypertonic | 1 | 2022 | 18 | 0.060 |
Why?
| Deoxyribonuclease I | 1 | 2022 | 41 | 0.050 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 35 | 0.050 |
Why?
| Oxygen Inhalation Therapy | 1 | 2021 | 16 | 0.050 |
Why?
| Middle Aged | 2 | 2013 | 13094 | 0.050 |
Why?
| Nutritional Status | 1 | 2021 | 158 | 0.050 |
Why?
| Anti-Bacterial Agents | 1 | 2006 | 816 | 0.040 |
Why?
| Societies, Medical | 1 | 2020 | 194 | 0.040 |
Why?
| Critical Care | 1 | 2021 | 234 | 0.040 |
Why?
| Self Efficacy | 1 | 2017 | 137 | 0.030 |
Why?
| Pandemics | 1 | 2020 | 575 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2017 | 304 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2017 | 637 | 0.030 |
Why?
| Numerical Analysis, Computer-Assisted | 1 | 2013 | 4 | 0.030 |
Why?
| Rheology | 1 | 2013 | 12 | 0.030 |
Why?
| Motion | 1 | 2013 | 20 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2015 | 272 | 0.030 |
Why?
| Quality of Health Care | 1 | 2015 | 222 | 0.030 |
Why?
| Patient Care Team | 1 | 2015 | 275 | 0.030 |
Why?
| Referral and Consultation | 1 | 2015 | 307 | 0.030 |
Why?
| Necrosis | 1 | 2007 | 207 | 0.020 |
Why?
|
|
Berlinski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|